{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "DXC",
  "name": "DXC Technology Company",
  "url": "https://orbyd.app/dossiers/DXC/",
  "json_url": "https://orbyd.app/dossiers/DXC.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Legacy IT-services decliner being re-rated as an AI-centric pivot: AI-framed leadership change 2026-07-30, ElevenLabs and Primary partnerships inside ten days, FY27 non-GAAP EPS guide of $2.40–$2.90 affirmed against a $10.84 close. Headlines and valuation are doing the work while organic revenue fell 6.7% in Q1 FY27 and the Q2 EPS guide of ~$0.55 sits well under the $0.70 consensus. No dated catalyst inside 30 days.",
  "invalidation_trigger": "A weekly close below $10.00 gives back the post-2026-07-30 advance and returns price to the range that produced the 29.7% drawdown from $15.43; secondary, FY2027 non-GAAP EPS guidance of $2.40–$2.90 being cut at the Q2 print (~2026-10-29, est.).",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "cyclical-industrials",
    "ai-datacenter-infrastructure",
    "ai-enterprise-software",
    "small-cap-value-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends March 31: 'Q1 FY2027' is the quarter ended 2026-06-30 and FY2027 ends 2027-03-31.",
    "Q1 FY27 GAAP diluted EPS ($0.73) exceeded non-GAAP ($0.40) because of $214M litigation cash — reported-EPS screens misread this quarter.",
    "Roughly half the revenue is non-US across five geographic markets, so reported vs organic revenue diverge with the dollar (-5.1% vs -6.7% in Q1 FY27).",
    "The only capital return disclosed in the Q1 FY27 release is buyback: $70M, about 6.7M shares.",
    "All three price targets updated after the 2026-07-30 print came from Hold or Sector Perform ratings — none from a buy-rated house."
  ],
  "body_markdown": "## Current Thesis\nThe leg on offer is a legacy pivot: a ~$12B-revenue IT services business in multi-year organic decline being re-rated on an AI-centric repositioning. The dated evidence for the repositioning is recent and dense — an ElevenLabs voice-AI partnership announced 2026-07-28, a leadership reshuffle on 2026-07-30 that installed Paul Taylor as president (Raul Fernandez remains CEO) and Dan Gray as president of Global Infrastructure Services under a \"dual Core and Fast Track\" framing, and a 2026-08-06 deal making DXC the exclusive managed services provider for Primary's AI-native zero-trust platform. Against that, FY2027 non-GAAP EPS guidance of $2.40–$2.90 was affirmed on 2026-07-30 while the close on 2026-08-07 was $10.84.\n\nLife-cycle label: **ACCELERATING**, and the acceleration is in attention rather than in the P&L. What dates it: three AI-framed corporate announcements in the ten sessions from 2026-07-28 to 2026-08-06, TD Cowen lifting its price target from $10 (2026-07-09) to $12 (2026-08-03) four sessions after the print, and a +15.0% three-month return with RSI(14) at 68.9. What argues against calling it more than that: every recent rating action came from a neutral stance, and the operating line went the other way — organic revenue fell 6.7% in the June quarter and the September-quarter EPS guide of ~$0.55 sits well below the $0.70 consensus.\n\n## Bull Case\n- **Bookings turned before revenue.** Q1 FY27 bookings $3.0B, +5% YoY, book-to-bill 0.99x — the highest first-quarter level in three years, with trailing-twelve-month book-to-bill slightly above 1.0 (Q1 FY27 earnings call, 2026-07-30). In services, the order book moves first; revenue follows or it does not.\n- **The year was affirmed after a soft quarter.** On 2026-07-30 management held FY2027 non-GAAP EPS at $2.40–$2.90, adjusted EBIT margin at 6.0%–7.0%, free cash flow at approximately $685M, and organic revenue at -5.0% to -3.0% (widening the revenue range only to $12.100B–$12.350B from $12.110B–$12.350B).\n- **Cash generation stepped up.** Q1 FY27 free cash flow $314M versus $97M in the prior-year quarter, and the company repurchased $70M of stock (~6.7M shares) in the quarter.\n- **Balance sheet is not the constraint today.** Cash and equivalents $1,957M against total short- plus long-term debt $3,504M at 2026-06-30.\n- **One segment is growing.** Insurance Software & Services revenue $319M, +1.4% organic in Q1 FY27 — the only segment with a positive organic line.\n- **Sell-side band brackets the price.** RBC maintained Sector Perform with a $14 target on 2026-07-31; TD Cowen's Hold target moved up to $12 on 2026-08-03. The 2026-08-07 close of $10.84 sits beneath both.\n\n## Bear Case\n- **The near quarter was guided down hard.** Q2 FY27 guidance issued 2026-07-30: non-GAAP EPS ~$0.55 against a $0.70 consensus, revenue $2.970B–$3.000B against $3.018B consensus, organic revenue -6.5% to -5.5%.\n- **The largest segment is shrinking double digits.** GIS revenue $1,449M, -11.1% organic in Q1 FY27; Consulting & Engineering Services $1,231M, -3.0% organic. Total revenue $2.999B, -5.1% reported and -6.7% organic.\n- **The affirmed full-year range is back-half loaded.** Q1 adjusted EBIT margin printed 5.0%; Q2 is guided to approximately 6.0%; the FY27 band is 6.0%–7.0%. Holding the year requires the back half to run at or above the top of the annual range.\n- **Free-cash-flow quality.** Of the $314M Q1 FCF, $214M was cash proceeds from a litigation judgment; excluding it, free cash flow was $100M against an FY27 guide of roughly $685M.\n- **GAAP flattered the headline.** GAAP diluted EPS was $0.73 versus non-GAAP diluted EPS of $0.40 (down 41.2% YoY) — screens keyed to reported EPS will show the wrong number for this quarter.\n- **Coverage is uniformly neutral and the targets are moving both ways.** Stifel maintained Hold and cut to $10.50 on 2026-07-31; RBC cut to $14 the same day; TD Cowen raised to $12 on 2026-08-03. The close is already above Stifel's target.\n- **Currency helped.** Reported revenue declined 5.1% while organic declined 6.7%; translation was a tailwind in the quarter, and it is not a repeatable one.\n\n## Setup & Price Structure\n- Last completed daily close $10.84 (2026-08-07). 52-week high $15.43, leaving price 29.7% below it. Three-month return +15.0%. RSI(14) 68.9.\n- Inferred, not measured: a 69 RSI while price sits nearly 30% under the 52-week high describes a sharp bounce inside a longer downtrend, not a completed base. The $12–$15.43 band is where the past year's supply was created, and none of it has been worked through.\n- Positioning and crowding observables, stated as observables: three post-print analyst actions in five sessions (2026-07-31 Stifel $10.50, 2026-07-31 RBC $14, 2026-08-03 TD Cowen $12), all from Hold/Sector Perform ratings, none an upgrade; the close sits above the lowest of the three targets. Disclosed share activity in the period is corporate rather than insider — $70M of buybacks in Q1 FY27; no recent insider transactions surfaced in the filing record reviewed for this note.\n- There is no company-dated event between 2026-08-08 and 2026-09-07 to resolve anything. The rally is running into a calendar vacuum, with the next hard datapoint roughly eleven weeks out.\n- Level that matters for the structure: the $10 area. Below it, the July–August advance off the print has been given back and the chart returns to the range that produced the 52-week decline.\n\n## Catalyst Calendar (next 30 days)\n- **No confirmed DXC event falls inside 2026-08-08 to 2026-09-07.** The 30-day window is empty of scheduled company catalysts; anything that moves the name in this window is unscheduled (contract announcements, partnership headlines, sector re-rating).\n- **2026-09-30** — close of the guided fiscal Q2 (non-GAAP EPS ~$0.55, organic revenue -6.5% to -5.5%). The quarter being measured ends here even though it is not reported here.\n- **~2026-10-01 (est.)** — earnings scheduling press release for Q2 FY27. Precedent: the Q1 equivalent was issued 2026-06-25 for a 2026-07-30 print.\n- **~2026-10-29 (est.)** — Q2 FY27 results. Precedent: Q2 FY26 was released 2025-10-30; Q2 FY25 on 2024-11-07. This is the first test of both the ~$0.55 quarter and the affirmed $2.40–$2.90 full-year range.\n\n## What Would Change Our Mind\nThe load-bearing assumption is that the affirmed FY27 range survives an H2 that has to run above the top of its own 6.0%–7.0% margin band after a 5.0% Q1. If the Q2 print (~2026-10-29, est.) trims FY27 non-GAAP EPS toward or below the $2.40 floor, or cuts the ~$685M free-cash-flow guide, the valuation leg loses its anchor and the AI-partnership headlines are left carrying the story alone.\n\nOn price, a weekly close below $10.00 gives back the advance built after the 2026-07-30 print and puts the name back inside the range that produced the 29.7% drawdown from $15.43 — that is the gradeable break.\n\nSecond condition, on the narrative: further AI-partnership announcements without a corresponding move in bookings or margin would date this as SATURATED rather than accelerating. The specific observable is trailing-twelve-month book-to-bill falling back below 1.0, or GIS organic decline steeper than the -11.1% posted in Q1 FY27.\n\nWhat would strengthen the case instead: book-to-bill sustained above 1.0 with GIS decline compressing to single digits at the Q2 print, alongside an FY27 EPS range narrowed upward off the $2.40 floor and free cash flow tracking the ~$685M guide without one-off litigation cash inside it.\n\n## Correlation Notes\n- Moves with the legacy IT-services complex — Kyndryl, Cognizant, Unisys, Capgemini, Atos, the Indian offshore names. The shared factor is enterprise discretionary IT spend and the market's live argument over whether agentic AI compresses headcount-linked services revenue or expands the integration work around it. DXC sits on the compressed side of that argument: GIS -11.1% organic in the quarter ended 2026-06-30.\n- Currency is a real second-order driver. The Q1 FY27 gap between -5.1% reported and -6.7% organic means translation was additive; a stronger dollar reverses the direction of that spread.\n- Leverage links it to rates: $3,504M total debt against $1,957M cash at 2026-06-30 makes refinancing terms a live variable if the ~$685M FCF guide slips.\n- Despite the AI framing in every recent headline, this is not an AI-capex or datacenter-hardware proxy. Any correlation to the semiconductor and datacenter-build complex is incidental; the revenue is enterprise services contracts, and the segment mix — GIS $1,449M, CES $1,231M, Insurance $319M — carries no compute-buildout exposure.",
  "first_seen": "2026-07-30",
  "last_analyzed": "2026-08-08T07:40:37+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}